Cyclafem 1/35 and Tri-iodothyronine uptake increased - from FDA reports


Summary

There is no Tri-iodothyronine uptake increased reported by people who take Cyclafem 1/35 yet. This review analyzes which people have Tri-iodothyronine uptake increased with Cyclafem 1/35. It is created by eHealthMe based on reports from FDA, and is updated regularly.

What to expect?

If you take Cyclafem 1/35 and have Tri-iodothyronine uptake increased, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Cyclafem 1/35 and have Tri-iodothyronine uptake increased

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Mar, 27, 2017

No report is found.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Tri-iodothyronine uptake increased when taking Cyclafem 1/35?

Cyclafem 1/35

Cyclafem 1/35 has active ingredients of ethinyl estradiol; norethindrone. It is often used in birth control. (latest outcomes from Cyclafem 1/35 135 users)

Tri-iodothyronine Uptake Increased

Tri-iodothyronine uptake increased has been reported by people with multiple sclerosis, hepatitis c, localised osteoarthritis, depression, hypothyroidism (latest reports from 22 Tri-iodothyronine uptake increased patients).

Browse all side effects of Cyclafem 1/35

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Tri-iodothyronine uptake increased

Tri-iodothyronine uptake increased

Could your condition cause Tri-iodothyronine uptake increased

Tri-iodothyronine uptake increased

Related studies